Browse by Medical Category
Accepting New Patients
Marcela del Carmen, MD, MPH, is a gynecologic oncologist at the Massachusetts General Hospital Cancer Center's Gillette Center for Gynecologic Oncology and the Department of Obstetrics & Gynecology.
Obstetrics & Gynecology
Go To Programs
Go To Specialties
Marcela G. del Carmen, MD, MPH is a graduate of the Johns Hopkins School of Medicine. She completed a residency in Gynecology and Obstetrics at Johns Hopkins Hospital and a fellowship in gynecologic oncology at Massachusetts General Hospital. She graduated with a Masters in Public Health from the Harvard School of Public Health. Dr. del Carmen was on the faculty at Johns Hopkins before returning to join the faculty at Massachusetts General Hospital. Dr. del Carmen is board certified in Obstetrics and Gynecology and Gynecologic Oncology. Dr. del Carmen is an Associate Professor at Harvard Medical School. She is a fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons, and a full member of the Society of Gynecologic Oncology, the International Gynecologic Cancer Society, and the New England Society of Gynecologic Oncologists. Dr. del Carmen is a member of the Ovarian Cancer Committee of the Gynecologic Oncology Group. Dr. del Carmen's research interests include the surgical treatment of gynecologic malignancies, specifically ovarian cancer, the management of rare gynecologic tumors and improving access to health care services for underserved populations. Dr. del Carme has been a principal investigator of clinical trials evaluating novel therapies in the treatment of ovarian cancer, as well as the design of a novel device for delivery of intra-peritoneal catheter.
View my most recent publications at PubMed
Bristow RE, del Carmen MG, Kaufman HS, Montz FJ. Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer. J Am Coll Surg. 2003;197(4):565-74.
del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. J Natl Cancer Inst. 2005;97(20):1516-24.
del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill C, Horowitz NS, Seiden MV. A comparison of demographics, risk factors, and screening knowledge between Latino and non-Latino women referred for colposcopy. Gynecol Oncol. 2007;104(1):70-76.
Orezzoli GP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG. Endometrioid adenocarcinoma of the endometrium: cervical stromal invasion does not correlate with overall survival. Gynecol Oncol. 2009;(113):316-23.
The critical topic of race in health care was the focus of a dynamic conversation during the annual YWCA Stand Against Racism event April 27 in Richard B. Simches Research Center.
Marcela G. del Carmen, MD, MPH, of the Department of Obstetrics and Gynecology, has been named the new MGPO medical director, starting Feb. 1.
Three MGHers have been awarded Harvard Medical School's Harold Amos Faculty Diversity Award.
THE RECIPIENTS OF THE Brian A. McGovern, MD, Award for Clinical Excellence were announced March 23 at the MGPO annual Physician Recognition Dinner at the Westin Boston Waterfront Hotel. The three honorees were selected from among 95 MGPO physicians nominated for their dedication, patient-centered care and clinical excellence. The award was created by the MGPO and is presented every 18 months to honor McGovern, a well-loved MGH cardiologist, who died in 2003.
MGH Hotline 12.04.09 The inspiration for creating the CBS Cares public service Pap smears web campaign – featuring MGH Department of Obstetrics and Gynecology Chief Isaac Schiff, MD, and gynecologic surgeon Marcela G. del Carmen, MD, MPH – began when a CBS Cares producer overheard a conversation between two women while dining at an Italian restaurant in Manhattan's West Village.
Marcela Del Carmen, MD, a gynecologic oncologist at the Massachusetts General Hospital Cancer Center says that the risk for cervical cancer goes up, not down, as you age. Learn about your risk for cervical cancer, and the new guidelines that caution women to continue to get PAP smears into their 60s.
Back to Top